Fresenius Medical Care AG & Co. KGaA ADR (FMS) News
Filter FMS News Items
FMS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
FMS News Highlights
- FMS's 30 day story count now stands at 2.
- Over the past 14 days, the trend for FMS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest FMS News From Around the Web
Below are the latest news stories about FRESENIUS MEDICAL CARE AG that investors may wish to consider to help them evaluate FMS as an investment opportunity.
Reasons to Retain Fresenius Medical (FMS) in Your Portfolio NowFresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe. |
Fresenius Medical Care says data on 500,000 people stolen in U.SFRANKFURT (Reuters) -Dialysis group Fresenius Medical Care said on Wednesday that data including medical records on 500,000 patients and former patients were stolen from a U.S. subsidiary's data warehouse. "The incident may have affected approximately 500,000 patients, former patients, guarantors and 200 staff located across several states, U.S. territories and four countries," the German company said in a statement. It said it launched an investigation with the help of a forensic firm after subsidiary Cardiovascular Consultants Ltd on Sept. 29 became aware of a security incident affecting some of its U.S. computer systems and an intruder claimed to have stolen data. |
Fresenius Medical Care completes change of legal form into a German stock corporationFresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announces the successful completion of its change of legal form from a partnership limited by shares (Kommanditgesellschaft auf Aktien, KGaA) into a German stock corporation (Aktiengesellschaft, AG) as of November 30, 2023. With this important milestone, Fresenius Medical Care is opening a new chapter in the history of the Company with a simplified corporate governance structure tha |
Only Have $100? 3 No-Brainer Stocks to Buy Right NowThe stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks. |
Be Wary Of Fresenius Medical Care KGaA (ETR:FME) And Its Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? One common... |
Fresenius Medical (FMS) Ups '23 Outlook After Legal SettlementFresenius Medical (FMS) wins legal dispute against the U.S. government. Both revenues and operating income will benefit from the settlement agreement. |
Fresenius Medical Care enters into favorable settlement agreement with U. S. government with positive earnings impact of approx. EUR 175 million - 2023 earnings outlook raisedFresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, resolved a legal dispute with the U.S. government, for accounts receivable in legal dispute, and entered into a final and legally binding settlement agreement today, whereby the company will receive a payment from the U.S. government. |
Cytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call TranscriptCytosorbents Corporation (NASDAQ:CTSO) Q3 2023 Earnings Call Transcript November 9, 2023 Cytosorbents Corporation misses on earnings expectations. Reported EPS is $-0.20718 EPS, expectations were $-0.12. Operator: Good afternoon, and welcome to CytoSorbents third quarter 2023 financial and operating results conference call. [Operator Instructions]. Please be advised that the call will be recorded at the company’s […] |
At €32.00, Is Fresenius Medical Care AG & Co. KGaA (ETR:FME) Worth Looking At Closely?Let's talk about the popular Fresenius Medical Care AG & Co. KGaA ( ETR:FME ). The company's shares saw significant... |
Fresenius Medical (FMS) Q3 Earnings Miss, Operating Margin UpFresenius Medical's (FMS) third-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income. |